As of 2026-09-28, the EV/EBITDA ratio of Willow Biosciences Inc (WLLW.TO) is
-37.60.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. WLLW.TO's latest enterprise value
is 107.58 mil CAD. WLLW.TO's TTM EBITDA according to its financial statements is
-2.86 mil CAD. Dividing these 2
quantities gives us the above WLLW.TO EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
0.1x - 0.8x |
0.1x |
| Forward P/E multiples |
1.8x - 2.5x |
2.2x |
| Fair Price |
(0.00) - 0.19 |
0.08 |
| Upside |
-100.8% - 14.5% |
-50.0% |